SCPH - scPharmaceuticals, Inc. Net earnings per share (EPS TTM)
scPharmaceuticals Inc. possesses high growth potential driven by proprietary infusion systems that enable global sales expansion. Rolling trailing twelve-month net income per share reflects current dynamics, where the value of -1.81 serves as the current metric. The business remains crisis-resilient, as demand for heart failure therapy is stable. The company is currently aggressively implementing home-based treatment, displacing costly inpatient care.
Metric breakdowns and analytics for scPharma (SCPH)
- share price and expert price forecast:
- market capitalization statistics:
- business book valuation details:
- debt obligations and liquidity statistics:
Debt to Equity scPharmaceuticals Inc.|SCPH - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital scPharmaceuticals|SCPH - Company Total Debt|Debt to Book Capitalization Ratio scPharmaceuticals, Inc.|SCPH - Long-Term Liabilities|Company Short-Term Debts scPharmaceuticals|Quick Ratio scpharmaceuticals.com
- net income and valuation multiples indicators:
SCPH - Net Profit|Expected Profit scPharmaceuticals Inc.|SCPH - Company Value to Net Income|Future Price to Earnings scPharmaceuticals|SCPH - Price/Earnings to Growth Multiple|EV/EBITDA Multiple scPharmaceuticals, Inc.|SCPH - Operating profit EBITDA|Net earnings per share (EPS TTM) scPharmaceuticals|SCPH - Net earnings per share for the last 12 months|Quarterly EPS earnings growth scpharmaceuticals.com|SCPH - Earnings per share growth rate in current year|Expected earnings per share growth for next year scPharmaceuticals Inc.
- revenue and sales proceeds data:
Initial company analysis:SCPH - scPharmaceuticals
Analyzing the change in TTM net income per share allows for an assessment of the efficiency of scPharmaceuticals Inc. (SCPH) within the high-tech drug distribution segment. This indicator reflects the final profit distributed across the total volume of shares, making it possible to identify a hidden decline in margins even amid sales growth, should the costs of complex pharmaceutical logistics begin to outpace revenue growth rates.
Key competitors
Haleon - Net earnings per share (EPS TTM)|Kenvue - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Corp - Earnings per share for the trailing year|LGND (Ligand Pharmaceuticals Incorporated) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months amneal.com AMRX|Earnings per share for the last twelve months Perrigo (PRGO)|ALVO (Alvotech SA) - Earnings per share for the trailing year|Earnings per share for the last twelve months Liquidia Technologies LQDA|Net earnings per share for the trailing year Galapagos Genomics|ANIP - Earnings per share for the last twelve months|MNKD - Net earnings per share (EPS TTM)|Amphastar Pharmaceuticals (AMPH) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Pacira BioSciences, Inc.|Net earnings per share for the last 12 months SPRY|TBPH: Earnings per share for the trailing year|Earnings per share for the last twelve months aquestive.com (AQST)|TECX - Net earnings per one share for the last twelve months|Tonix Pharmaceuticals Holding Corp. - Net earnings per share for the last 12 months|Earnings per share for the trailing year SXTC|Eupraxia Pharmaceuticals, Inc. - Net earnings per share (EPS TTM)|BHST: Earnings per share for the last twelve months|invizyne.com (EXOZ) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ORMP (Oramed)|ENTX (Entera Bio) - Net earnings per share (EPS TTM)|HYFT: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ABVC|Cumberland Pharmaceuticals - Earnings per share for the last 12 months|Earnings per share for the last twelve months Quantum BioPharma Ltd. QNTM|FGEN: Earnings per share for the last 12 months|TELO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Rani Therapeutics Holdings|SNYR: Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months RLYB (Rallybio Corp.)|LEXX (Lexaria Bioscience Corp.) - Net earnings per share (EPS TTM)|pulmatrix.com (PULM) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pheton (PTHL)|Net earnings per share for the last four quarters Aptorum Group Ltd|Net earnings per share (EPS TTM) LYRA (Lyra Therapeutics Inc)|Impact BioMedical - Earnings per share for the last twelve months|TNF Pharmaceuticals - Net earnings per share (EPS TTM)|YCBD - Net earnings per share (EPS TTM)|PRFX: Net earnings per share (EPS TTM)|CYTO: Earnings per share for the last four quarters|LIPO (Lipella Pharma) - Net earnings per share (EPS TTM)|OPTN: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PIRS|PROC (procapsgroup.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Petros Pharmaceuticals, Inc. PTPI|Qilian International Holding - Earnings per share for the last twelve months|SLRN - Earnings per share for the last twelve months|Earnings per one share for the last 12 months TFFP
